Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 6,904 | 7,548 | 12,206 | 37,164 | 18,193 |
| Gross Profit | 6,904 | 7,548 | 12,206 | 37,164 | 18,193 |
| Operating Expenses | 30,425 | 32,715 | 29,558 | 29,123 | 27,780 |
| Operating Income | -23,521 | -25,167 | -17,352 | 8,041 | -9,586 |
| Interest Expense | 3,011 | 4,444 | 10,211 | 10,912 | 19,695 |
| Other Income | 4,739 | 11,893 | 821 | 3,460 | 5,545 |
| Pre-tax Income | -21,793 | -17,718 | -26,742 | 589 | -23,736 |
| Income Tax | 25 | 46 | N/A | N/A | N/A |
| Net Income Continuous | -21,819 | -17,765 | -26,318 | 589 | -23,736 |
| Net Income | $-21,819 | $-17,765 | $-26,318 | $589 | $-23,736 |
| EPS Basic Total Ops | -0.22 | -0.18 | -0.26 | 0.01 | -0.24 |
| EPS Basic Continuous Ops | -0.22 | -0.18 | -0.26 | 0.01 | -0.24 |
| EPS Diluted Total Ops | -0.22 | -0.18 | -0.26 | 0.01 | -0.24 |
| EPS Diluted Continuous Ops | -0.22 | -0.18 | -0.26 | 0.01 | -0.24 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.18 | -0.26 | 0.01 | -0.24 |
| EBITDA(a) | $-19,109 | $-20,632 | $-12,249 | $13,052 | $-4,570 |